Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Dapagliflozin Therapy on Right Ventricular Remodeling Following Transcatheter Atrial Septal Defect Closure in Adults: Randomized Clinical Trial

NCT07823972 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT07823972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07823972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Dapagliflozin Therapy on Right Ventricular Remodeling Following Transcatheter Atrial Septal Defect Closure in Adults: Randomized Clinical Trial
Lead sponsor
Assiut University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
January 30, 2029
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asd2(secundum atrial septal defect)